Hydroxy acids and derivatives
Medchemexpress LLC Iron II D-gluconate 1kg
Iron(II) D-gluconate dihydrate 98% is used for blood coagulation
Medchemexpress LLC Gluconate Calcium | 299-28-5 | 98.0% | 1 ML
Gluconate Calcium is an orally active glucose derivative that demonstrates antioxidant and antiplatelet activation activities. It has been shown to reduce nitric oxide and inflammatory cytokines, inhibit ERK phosphorylation, and exhibit antitumor activity against colorectal cancer. It also improves conditions such as osteoarthritis, intestinal damage, and acute lung injury.
- Orally active glucose derivative
- Reduces nitric oxide and inflammatory cytokines
- Inhibits ERK phosphorylation
- Possesses antioxidant and antiplatelet activation activities
- Demonstrates antitumor activity against colorectal cancer
- Improves osteoarthritis, intestinal damage, and acute lung injury
- Inhibits thrombin-induced arachidonic acid peroxidation and superoxide anion production in platelets
- Reduces platelet protein oxidation/nitration, carbonyl group generation, thiol oxidation, and nitrotyrosine formation
Medchemexpress LLC Iron(II) gluconate | 699014-53-4 | MFCD00150872 | 91.3% | 464.15 | C12H22FeO14·xH2O | 100 MG
Iron(II) gluconate is the ferrous salt of gluconic acid supplied as a light yellow to brown solid. It is used as a source of ferrous iron (Fe(II)) in biochemical assays and laboratory research; for research use only and not for human consumption.
- Provides ferrous iron (Fe(II)) for biochemical and assay applications.
- Assay/purity approximately 91.3%.
- Available in small laboratory sizes (25 mg, 50 mg, 100 mg; larger sizes by quote).
- Solid form with light yellow to brown appearance for ease of handling and storage.
- Certificate of analysis, safety data sheet, and handling instructions available.
- Intended for research use only; not for clinical or human use.
Medchemexpress LLC Gluconate sodium (D-gluconic acid sodium salt) | 527-07-1 | ≥98.0% | 500 G
Gluconate sodium (D-Gluconic acid sodium salt) is an orally active glucose derivative. It reduces nitric oxide and inflammatory cytokines, inhibits ERK phosphorylation, and possesses antioxidant and antiplatelet activation activities. Additionally, it demonstrates antitumor activity against colorectal cancer and has shown improvements in osteoarthritis, intestinal damage, and acute lung injury.
- Reduces nitric oxide and inflammatory cytokines (IL-1β and IL-6)
- Inhibits ERK phosphorylation
- Possesses antioxidant and antiplatelet activation activities
- Exhibits antitumor activity against colorectal cancer
- Improves osteoarthritis, intestinal damage, and acute lung injury
Medchemexpress LLC Sodium Tartrate | 868-18-8 | 99.0% | 25 MG
Sodium Tartrate is a pH-regulating agent with antioxidant activity. It is particularly effective in retarding hydrolysis when heated at high temperatures, which can increase the acid values (AVs) of vegetable oils.
- Acts as a pH-regulating agent
- Exhibits antioxidant activity
- Effective in retarding hydrolysis at high temperatures
Medchemexpress LLC Metoprolol tartrate | 56392-17-7 | MFCD00056257 | 100.0% | 342.41 g·mol⁻¹ | C19H31NO9 | 10 MG
Metoprolol tartrate is the tartrate salt of metoprolol, a selective β1-adrenoceptor antagonist used in research to study β1 receptor pharmacology and cardiovascular effects. It is supplied as a purified chemical reference for in vitro and preclinical studies, and has been reported to exhibit anti-inflammatory, antitumor, and anti-angiogenic activities.
- Selective β1-adrenoceptor antagonist for receptor pharmacology studies.
- Documented anti-inflammatory, antitumor, and anti-angiogenic properties.
- High purity suitable for analytical and experimental use.
- Available in small research pack sizes for assay development.
- Suitable as a chemical reference standard in in vitro and preclinical assays.
- Solid form, compatible with standard laboratory handling procedures.
Medchemexpress LLC 2-hydroxybutyric acid (α-hydroxybutyric acid) | 600-15-7 | 98.0% | 104.10 | 1 G
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is an endogenous metabolite, converted from 2-Aminobutyric acid. It serves as a potential biomarker for type 2 diabetes and preeclampsia and has shown the ability to prevent acetaminophen (AP)-induced liver injury. This compound is synthesized as a coproduct of insulin resistance, contributing to insulin signaling impairment and mitochondrial overload.
- Enhances cell viabilities and decreases AP-induced toxicities in BRL3A, AML12, and mice primary hepatocytes.
- Prevents AP-induced liver injury in C57 mice.
- Normalizes gene expressions related to inflammation response, oxidative stress, cell proliferation, and DNA damage.
Medchemexpress LLC 3-Hydroxybutyric acid-13C4 sodium | 287111-43-7 | 98.0% | 130.06 | 1 MG
3-Hydroxybutyric acid-13C4 sodium is a 13C labeled form of 3-Hydroxybutyric acid sodium. This metabolite is elevated in type I diabetes and can modulate the properties of membrane lipids. It is intended for research use only.
- Can be used as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Incorporates stable heavy isotopes as tracers for quantitation during drug development
- Deuteration may affect pharmacokinetic and metabolic profiles of drugs